Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-EN Version v1-EN
Language English English
Date Updated 2017-09-22 2017-07-25
Drug Identification Number 00592277 00592277
Brand name APO NAPROXEN TAB 500MG APO NAPROXEN TAB 500MG
Common or Proper name NAPROXEN NAPROXEN
Company Name APOTEX INC APOTEX INC
Ingredients NAPROXEN NAPROXEN
Strength(s) 500MG 500MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 500 BTL 500 BTL
ATC code M01AE M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-07-24 2017-07-24
Estimated end date 2017-08-11 2017-08-11
Actual end date 2017-08-11
Shortage status Resolved Actual shortage
Company comments 100 BTL available 100 BTL available
Health Canada comments